At present, the main clinical screening methods of PCa were serum prostate-specific antigen (PSA), digital rectal examination (DRE), magnetic resonance imaging (MRI) and transrectal ultrasound (TRUS) (4). Here, KLK3 is linked to posterior cortical atrophy.